Market Access: MedTech

Value-Based Access Programs

Communicating value to the market

Alira Health has the industry and market experience to communicate the value of your healthcare device or life science innovation. We specialize in helping early stage developers and late stage innovators communicate the hidden value of their products, increasing market access.

Solutions designed for commercial success

Our Center for Healthcare Economics and Outcomes Research (HEOR) team provides a range of solutions to communicate your value to the market and ensure commercial success. Our team works closely with clients to:
  • Identify key solutions that when implemented would satisfy a clear unmet need
  • Align internal messaging around the MAP™ diagnostic
  • Engage external stakeholders and develop a project charter
  • Identify local sites and clinical engagement
  • Monitor and track identified outcomes
  • Determine viability of program
  • Develop outcomes report
  • Scale up where possible

Why choose Alira Health?

Our fully integrated market access team understands the nuances of launching in today’s market. As your partner, we’ll provide:

  • Access to a diverse, integrated team with deep industry expertise
  • Close collaboration with our regulatory and clinical practices to support a holistic commercialization strategy
  • Specific, local insights as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Richard Charter
Richard Charter
Vice President, Market Access, MedTech, Europe and Asia-Pacific
Our holistic, lifecycle approach to market access provides clients with maximum clinical and economic value for their technology while supporting patient-centered, value-based healthcare.

Related News

Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.